Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04739371 · ClinicalTrials.gov registry record · Phase 1
Food Intake and Intra-Nasal Insulin for African American Adults (FIINAAL)
A Phase 1 study, sponsored by Pennington Biomedical Research Center.
- Completed
- Registry status
- Phase 1
- Development phase
- 40
- Enrollment target
NCT04739371 is a Phase 1 study that has completed, run by Pennington Biomedical Research Center. The registered enrollment target is 40 participants.
The verdict
NCT04739371, a Phase 1 study, has completed, sponsored by Pennington Biomedical Research Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 40 participants
- Enrollment target
Study Summary
The purpose of this research study is to investigate brain insulin's relationship with food intake in African Americans. Facilitating insulin's entrance into the brain through a nasal spray is currently being studied as a way to prevent or treat Alzheimer's disease. However, brain insulin may also have an impact on food intake. This study is designed to help researchers understand how different factors related to Alzheimer's disease (i.e. APOE genotype and cognitive functioning) influence brain insulin's relationship with food intake.
Interventions
- DRUG Placebo
- DRUG Insulin, Regular, Human
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2021-06-17 |
| Est. Completion | 2022-06-07 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04739371
The ClinicalTrials.gov registry entry for NCT04739371 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pennington Biomedical Research Center, which has 258 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT04739371 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04739371 about?
NCT04739371 is a clinical study titled "Food Intake and Intra-Nasal Insulin for African American Adults (FIINAAL)". The purpose of this research study is to investigate brain insulin's relationship with food intake in African Americans. Facilitating insulin's entrance into the brain through a nasal spray is currently being studied as a way to prevent or treat Alzheimer's disease. However, brain insulin may also h...
What is the current status of trial NCT04739371?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 40 participants. The study started on 2021-06-17. Estimated completion is 2022-06-07.
What interventions are being tested in trial NCT04739371?
The interventions under investigation include: Placebo (DRUG), Insulin, Regular, Human (DRUG).
Who is sponsoring clinical trial NCT04739371?
This trial is sponsored by Pennington Biomedical Research Center, which has 258 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.